EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD8+ T cell differentiation into NK-like effector cells drives transplant rejection

Dawei Zou, Stephanie G Yi, Yulin Dai, Luan Truong, Lillian W Gaber, Richard J Knight, Xiang Xiao, Rafik M Ghobrial, Xian C Li, Zhongming Zhao, Wenhao Chen, A Osama Gaber

Molecular Therapy · 2026-05 · 34 (5) · 2709-2724

DOI: 10.1016/j.ymthe.2026.01.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-05. Verfasst von Dawei Zou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Immunobiology & Transplant Science Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; Department of Su…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Graft Rejection, Cell Differentiation, Killer Cells, Natural. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NLM NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cells are central drivers of transplant rejection, yet the differentiation fates underlying this process remain unclear. Using single-cell transcriptomic profiling of human kidney allograft biopsies, we identified a predominant infiltrating CD8+ T cell subset exhibiting killer cell lectin-like receptor (KLR)+ natural killer (NK)-like features. Mechanistic studies in mice showed that the KLR+ subset emerged de novo post transplantation and dominated the CD8+ T cell infiltrate in rejecting allografts. These NK-like CD8+ T cells expressed high levels of interferon regulatory factor 4 (IRF4), and Irf4 deletion disrupted their differentiation and induced transplant acceptance. Therapeutically, either costimulation blockade or mammalian target of rapamycin (mTOR) inhibition substantially reduced the generation of NK-like CD8+ T cells; however, the persistence of these cells ultimately led to rejection. Notably, combining costimulation blockade with mTOR inhibition completely abrogated their generation and enabled transplant acceptance. Together, these findings identify KLR+ NK-like CD8+ T cells as key mediators of transplant rejection, highlighting the need for more effective strategies to block their differentiation and improve transplant outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesGraft RejectionCell DifferentiationKiller Cells, NaturalKidney TransplantationAnimalsMiceHumansInterferon Regulatory FactorsInterferon Regulatory Factor-4TOR Serine-Threonine KinasesGene Expression ProfilingBiomarkers

Stichwörter der Autor:innen

CD8(+) T cell differentiationIRF4NK-likeT cellcostimulation blockadekidney transplantationrapamycinscRNA-seqtransplant rejection

Substanzen

Interferon Regulatory FactorsInterferon Regulatory Factor-4TOR Serine-Threonine KinasesBiomarkers

Autor:innen und Institutionen

  • Immunobiology & Transplant Science Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; Department of Surgery, Weill Cornell Medical College, New York, NY 10065, USA.
  • Immunobiology & Transplant Science Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX 77030, USA;…
  • Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX 77030, USA.
  • J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX 77030, USA; Department of Surgery, Houston Methodist Hospital, Houston, TX 77030, USA; Department of Surgery, Weill Cornell Medical College, New…
  • Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center, UTHealth Hou…

Förderung

  • NLM NIH HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Library of Medicine
  • Houston Methodist Research Institute
  • National Institutes of Health
  • American Society of Transplantation
  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Zou, D., Yi, S. G., Dai, Y., Truong, L., Gaber, L. W., Knight, R. J., Xiao, X., Ghobrial, R. M., Li, X. C., Zhao, Z., Chen, W., & Gaber, A. O. (2026). CD8+ T cell differentiation into NK-like effector cells drives transplant rejection. Molecular Therapy, 34(5), 2709-2724. https://doi.org/10.1016/j.ymthe.2026.01.024

Vancouver

Zou D, Yi SG, Dai Y, Truong L, Gaber LW, Knight RJ, et al. CD8+ T cell differentiation into NK-like effector cells drives transplant rejection. Molecular Therapy. 2026;34(5):2709-2724. doi:10.1016/j.ymthe.2026.01.024

BibTeX
@article{Zou2026,
  author = {Zou, Dawei and Yi, Stephanie G and Dai, Yulin and Truong, Luan and Gaber, Lillian W and Knight, Richard J and Xiao, Xiang and Ghobrial, Rafik M and Li, Xian C and Zhao, Zhongming and Chen, Wenhao and Gaber, A Osama},
  title = {CD8+ T cell differentiation into NK-like effector cells drives transplant rejection},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {5},
  pages = {2709--2724},
  doi = {10.1016/j.ymthe.2026.01.024}
}
Kostenlos starten →